Summary
This abstract describes molecular mechanistic work characterising ROR1 as a dual-function protein in lung adenocarcinoma: functioning both as a ligand-independent sustainer of pro-survival PI3K-AKT signalling and as a kinase-independent structural scaffold for caveolar proteins CAVIN1 and caveolin-1. The authors propose that ROR1-mediated maintenance of caveolae structures and function enables sustained endocytosis and signalling through multiple receptor tyrosine kinases, potentially explaining resistance to single-agent EGFR tyrosine kinase inhibitors. The work suggests ROR1 as a therapeutic target for overcoming bypass signalling mechanisms in lung adenocarcinoma.
UK applicability
This is fundamental cancer cell biology research with potential future translational implications for precision oncology. UK clinicians and researchers may find value in the mechanistic insights for developing combination therapies targeting ROR1 in EGFR-TKI-resistant lung adenocarcinoma, though the findings require further clinical validation.
Key measures
ROR1-CAVIN3 and ROR1-CAV1 protein interactions; caveolae structure and function; PI3K-AKT pro-survival signalling; ASK1-p38 pro-apoptotic signalling; receptor tyrosine kinase (EGFR, MET, IGF-IR) internalisation and recycling
Outcomes reported
The study investigated the role of ROR1 receptor tyrosine kinase interaction with CAVIN3 and caveolin-1 in regulating caveolae-dependent endocytosis and pro-survival signalling in lung adenocarcinoma cells. The research characterised how ROR1 functions as a kinase-independent scaffold for caveolar structural proteins, sustaining growth factor signalling through multiple receptor tyrosine kinases.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.